Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
60 /100
HIGH RISK
Score updated Aug 28, 2026

CRBP — Corbus Pharmaceuticals Holdings, Inc. Dilution Risk Tracker

Track CRBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CRBP — Get alerts when the score changes →

As of August 28, 2026, Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. Corbus Pharmaceuticals Holdings, Inc. has a market capitalization of $146.55M, 19.34M shares outstanding, 107 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M, 2.9K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
25
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 13%
💰 Capital Raise model 20%
• Active shelf registration ($300M, 205% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (60/100)
🔔 Track CRBP — Get forecast alerts →

Market Data

Market Cap$146.55M
Shares Outstanding19.34M
Float12.74M
Cash$117.94M
Debt$12.76M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.9% shares (2026Q1 vs prior)
107 institutional holders · 14.75M shares
#1 Cormorant Asset Management, LP 2.34M shares
#2 ORBIMED ADVISORS LLC 1.74M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.47M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.30M
Days to Cover9.4
% of Float18.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2014-12-31
S-3 SHELF 2026-03-11
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-02-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual CRBP Dilution Snapshot

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a DilutionScore of 60/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CRBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRBP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CRBP
CRBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.